USA300
The Sle1 Cell Wall Amidase Controls Daughter Cell Splitting, Cell Size, and betalactam Resistance in Community Acquired Methicillin Resistant Staphylococcus aureus USA300:
Most clinically relevant methicillin resistant Staphylococcus aureus (MRSA) strains have become resistant to betalactams antibiotics through horizontal acquisition of the mecA gene encoding PBP2a, a peptidoglycan transpeptidase with low affinity for betalactams. The level of resistance conferred by mecA is, however, strain dependent and the mechanisms underlying this phenomenon remain poorly understood. We here show that betalactam resistance correlates to expression of the Sle1 cell wall amidase in the fast spreading and highly virulent community-acquired MRSA USA300 clone. Sle1 is a substrate of the ClpXP protease, and while the high Sle1 levels in cells lacking ClpXP activity confer betalactam hyper-resistance, USA300 cells lacking Sle1 are as sensitive to betalactams as cells lacking mecA. This finding prompted us to assess the cellular roles of Sle1 in more detail, and we demonstrate that high Sle1 levels accelerate the onset of daughter cells splitting and decrease cell size. Vice versa, oxacillin decreases the Sle1 level, and imposes a cell-separation defect that is antagonized by high Sle1 levels, suggesting that high Sle1 levels increase tolerance to oxacillin by promoting cell separation. In contrast, increased oxacillin sensitivity of sle1 cells appears linked to a synergistic lethal effect on septum synthesis. In conclusion, this study demonstrates that Sle1 is a key factor in resistance to betalactam antibiotics in the JE2 USA300 model strain, and that PBP2a is required for expression of Sle1 in JE2 cells exposed to oxacillin.